SCHEMBL18544756

SCHEMBL18544756

CN1CCN(CP(C)(C)=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
PAOX Q6QHF9 1/20 0.36
MAPT P10636 1/20 0.34
MC4R P32245 1/20 0.34
HDAC6 Q9UBN7 2/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
TSHR P16473 1/20 0.32
SIGMAR1 Q99720 2/20 0.31
CHKA P35790 1/20 0.31
HTR1A P08908 1/20 0.30
PHGDH O43175 1/20 0.30
MGLL Q99685 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24359640 0.89 KDM4E (0.50) ALDH1A1KDM4EPOLBMAPT
SCHEMBL20352233 0.80 KDM4E (0.43) ALDH1A1KDM4EPOLBMAPT
SCHEMBL8580833 0.79 MAPT (0.54) ALDH1A1KDM4EPOLBMAPTLMNA
SCHEMBL24359638 0.78 MAPT (0.43) ALDH1A1KDM4EPOLBMAPTCYP1A2
SCHEMBL18538905 0.75 KDM4E (0.48) ALDH1A1KDM4EPOLBMAPTLMNA
SCHEMBL14444588 0.75 PAOX (0.46) ALDH1A1KDM4EPOLBPAOXTSHR
SCHEMBL14190592 0.73 POLB (0.38) ALDH1A1KDM4EPOLBMAPTLMNA
SCHEMBL2701173 0.73 POLB (0.38) ALDH1A1KDM4EPOLBMAPTLMNA
SCHEMBL11453595 0.73 KDM4E (0.38) ALDH1A1KDM4EPOLBMAPT
SCHEMBL14444593 0.73 ALDH1A1 (0.38) ALDH1A1KDM4EPOLBPAOXMC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3337483-B1 NOVEL ANNELATED BENZAMIDES BOEHRINGER INGELHEIM INT (DE) 2019-10-09 EP disclosed
US-20170050952-A1 NOVEL ANNELATED BENZAMIDES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050952-A1 NOVEL ANNELATED BENZAMIDES HDAC10, HDAC11, H1-0 ALDH1A1 168/4885KDM4E 862/4885POLB 3848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.